FDA Doles Out First Nine Vouchers for Priority Drug Review

(MedPage Today) — The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday.
The nine companies selected to participate in the FDA Commissioner’s National Priority…

Source link : https://www.medpagetoday.com/washington-watch/fdageneral/118008

Author :

Publish date : 2025-10-17 19:57:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA Doles Out First Nine Vouchers for Priority Drug Review

Osteopathic Medical Schools Warn of Fallout From Federal Shutdown

‘Nightmare’ calculation may be too tricky for even quantum computers

Related Posts

Rare Childhood Disorder Gets Its First FDA Drug Approval

FDA Says to Drop Suicide Warning From GLP-1 Drug Labels

Mystery Brain Disease in Canada; Alzheimer’s Clinical Trial Lawsuit; Brains in Space

‘Misleading’ Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF

Streeting Moves to Favour UK Graduates for NHS Training

EPA Will Stop Calculating the Economic Savings to Health in Key Air Pollution Rules

Rare Childhood Disorder Gets Its First FDA Drug Approval

FDA Says to Drop Suicide Warning From GLP-1 Drug Labels

Mystery Brain Disease in Canada; Alzheimer’s Clinical Trial Lawsuit; Brains in Space

‘Misleading’ Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF

Streeting Moves to Favour UK Graduates for NHS Training

EPA Will Stop Calculating the Economic Savings to Health in Key Air Pollution Rules

Nurses Strike Enters Second Day at Major New York City Hospitals

Trump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet Recs

Categories

Archives